Especialidades y enfermedades
Farmacéuticas
Farmacéuticas. 25 de octubre de 2018
FEFE denuncia desabastecimiento en las farmacias de algunos medicamentos básicos
Carlos Gallinal, vicepresidente de FEFE: “Exigimos a los fabricantes farmacéuticos que solucionen este problema que afecta a la salud de muchos pacientes”.
Acceder
Farmacéuticas. 06 de septiembre de 2018
bioLIVE bio processing and manufacturing league table ranks US top and China bottom despite bio boom
Amsterdam, 6 September 2018: bioLIVE – the new bioprocessing and manufacturing event running alongside this year’s CPhI Worldwide – today announces the initial findings of the world’s first ever biopharma league table, which evaluates the reputations of major bio manufacturing countries across a number of characteristics (scored 1-10). This follows the launch of the small molecule pharma league table introduced last year.
Acceder
Farmacéuticas. 06 de septiembre de 2018
Plasticell wins military contract to develop regenerative medicines for the battlefield
Stevenage UK, 4 September 2018: Plasticell Ltd, a developer of stem cell technologies and regenerative medicines, has announced that it has been contracted by the Ministry of Defence (MoD) in a pilot programme to develop regenerative medicines for the treatment of injuries resulting from combat or terrorism.
Acceder
Farmacéuticas. 23 de agosto de 2018
CPhI Annual Report expert warns ‘innovation is being hindered by regulators’
Amsterdam, 23rd August 2018: CPhI Worldwide the world’s largest pharma event – taking place in Madrid October (9-11) and organized by UBM (part of Informa plc) – releases the first part of its 6th Annual Report with a stark warning from Girish Malhotra, President of EPCOT International, that regulators are holding back the industry’s ability to innovate.
Acceder
Farmacéuticas. 15 de agosto de 2018
Middle East and Africa pharma economy to reach US$38.8bn by 2021
Amsterdam, 15th August 2018: CPhI MEA (Middle East and Africa) launches next month as favourable market conditions are driving increased growth across the Middle East and North Africa (MENA) pharma market – ageing and gentrifying populations, increased healthcare spending, and a modernising supply chain are transforming prospects in the region.
Acceder
Farmacéuticas. 01 de agosto de 2018
WuXi STA’s Jinshan Site Passes Fourth U.S. FDA Inspection
SHANGHAI, August 1, 2018: STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, announces that its Active Pharmaceutical Ingredient (API) manufacturing facility at Jinshan (Shanghai, China) has successfully passed its fourth inspection from the U.S. Food and Drug Administration (USFDA) – with no Form 483s issued. The site previously passed three FDA inspections in 2013, 2014 and 2016.
Acceder
Farmacéuticas. 20 de julio de 2018
WuXi STA and Antengene Sign Development and Manufacturing Agreement
SHANGHAI, 20 July 2018: STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Antengene Corporation, a biopharmaceutical company, recently announced a strategic partnership for the CMC development and manufacturing of innovative oncology drugs. Under the terms of the collaboration, WuXi STA will provide Antengene an integrated solution in process R&D and manufacturing, using the MAH scheme to accelerate new drug development.
Acceder
Farmacéuticas. 09 de julio de 2018
Korea finished drug market growth driven by generics
Amsterdam, 9th July 2018: The Korean pharma market is experiencing significant growth in finished drug products, according to CPhI Korea. Over the last 12 months, market conditions have spurred a strong expansion in exports of finished formulations, driven primarily by an expanding domestic generics market.
Acceder
Subir
Subir notas de prensa y convocatorias
Próximas convocatorias
- Jornadas "HABLEMOS DE MARKETING FARMACÉUTICO, Farma Talks" de Cofano
- Fecha: 17 de noviembre de 2108
- Lugar: Edificio Cervantes, Santiago de Compostela
Ver todas
Especialidades
Busca notas de prensa por especialidad médica o enfermedad.
Archivo
Copyright © 2018, Farmavet, S.L. Todos los derechos reservados.
